Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orgapharm is a French contract development and manufacturing organization (CDMO) specializing in the production of active pharmaceutical ingredients (APIs) and fine chemicals. Based in Pithiviers, the company is a key subsidiary of the Axyntis Group and operates a significant GMP-compliant manufacturing site. Orgapharm provides services ranging from process development and pilot-scale production to full commercial manufacturing, with a particular expertise in complex chemical synthesis and hazardous chemistry. The company serves global pharmaceutical and biotechnology clients, supporting the development of small molecule therapeutics across various therapeutic areas. Its capabilities include high-pressure hydrogenation and the handling of sensitive reagents, making it a preferred partner for challenging chemical transformations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orgapharm.